citrulline and piperidines

citrulline has been researched along with piperidines in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fell, V; Pollitt, RJ1
Chell, MJ; El-Fakahany, EE; Linden, DR; Seybold, VS1
Bhardwaj, A; Goyagi, T; Hurn, PD; Kirsch, JR; Koehler, RC; Toung, TJ; Traystman, RJ1
Aydin, B; Cabadak, H; Kan, B; Küçükibrahimoğlu, E; Zafer Gören, M1

Other Studies

4 other study(ies) available for citrulline and piperidines

ArticleYear
3-Aminopiperid-2-one, an unusual metabolite in the urine of a patient with hyperammonaemia, hyperornithinaemia and homocitrullinuria.
    Clinica chimica acta; international journal of clinical chemistry, 1978, Aug-01, Volume: 87, Issue:3

    Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Chromatography, Gas; Chromatography, Ion Exchange; Citrulline; Electrophoresis; Humans; Mass Spectrometry; Ornithine; Piperidines; Piperidones

1978
Neurokinin(3) receptors couple to the activation of neuronal nitric-oxide synthase in stably transfected Chinese hamster ovary cells.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:2

    Topics: Animals; Calcium; Calcium Signaling; Cell Line; CHO Cells; Citrulline; Cricetinae; Cyclic GMP; Enzyme Activation; Guanylate Cyclase; Humans; Immunohistochemistry; Inositol Phosphates; Neurokinin B; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Piperidines; Rats; Receptors, Neurokinin-3; Transfection

2000
Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats.
    Stroke, 2003, Volume: 34, Issue:6

    Topics: Animals; Arginine; Cerebral Infarction; Citrulline; Corpus Striatum; Disease Models, Animal; Ischemic Attack, Transient; Male; Microdialysis; Neuroprotective Agents; Nitric Oxide; Piperidines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa; Treatment Outcome

2003
Muscarinic receptor-mediated nitric oxide release in a K562 erythroleukaemia cell line.
    Autonomic & autacoid pharmacology, 2009, Volume: 29, Issue:3

    Topics: Arginine; Carbachol; Chromatography, High Pressure Liquid; Citrulline; Dose-Response Relationship, Drug; Humans; K562 Cells; Microdialysis; Muscarinic Agonists; Muscarinic Antagonists; Nitric Oxide; Nitric Oxide Synthase; Piperidines; Receptors, Muscarinic; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tropicamide

2009